Liu X, Zhang Y, Zheng SY, Lin R, Xie YJ, Chen H, Zheng YX, Liu E, Chen L, Yan JH, Xu W, Mai TT, Gong Y
Head-to-head trials of treatment combinations: More head-to-head trials comparing different drug combinations would help establish optimal treatment algorithms in PCOS, which is characterized by a multi-system abnormality affecting multiple systems
GLP-1 receptors are widely expressed in myocardial and vascular systems 34 , and activation of these receptors may reduce cardiovascular risk by enhancing endothelial nitric oxide production 35,36 , modulating vascular tone, and reducing epicardial adipose tissue volume 37,38
This means ~7m annual revenue per DiGA